Shareholder Alert: The Ademi Firm investigates whether PharmChem, Inc. is obtaining a Fair Price for its Public Shareholders

MILWAUKEE, July 21, 2025 /PRNewswire/ -- The Ademi Firm is investigating PharmChem (OTC: PCHM) for possible breaches of fiduciary duty and other violations of law in its transaction with Alcohol Monitoring Systems.

Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995. There is no cost or obligation to you.

In the transaction, shareholders of PharmChem will receive $3.75 per share in cash. PharmChem insiders will receive substantial benefits as part of change of control arrangements.

The transaction agreement unreasonably limits competing transactions for PharmChem by imposing a significant penalty if PharmChem accepts a competing bid. We are investigating the conduct of the PharmChem board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.

We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts

Ademi & Fruchter LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001

SOURCE Ademi LLP